Korean J Radiol.
2022 Dec;23(12):1119-1125. 10.3348/kjr.2022.0834.
Randomized Clinical Trials of Artificial Intelligence in Medicine: Why, When, and How?
- Affiliations
-
- 1Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 2Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 3Department of Radiology, Université Paris Cité, AP-HP, Hôpital Européen Georges Pompidou, PARCC UMRS 970, INSERM, Paris, France
- 4Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
- KMID: 2536339
- DOI: http://doi.org/10.3348/kjr.2022.0834
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Artificial Intelligence for Improved Patient Outcomes—The Pragmatic Randomized Controlled Trial Is the Secret Sauce
- Artificial Intelligence in Pathology
- Concepts, Characteristics, and Clinical Validation of IBM Watson for Oncology
- Artificial intelligence in drug development: clinical pharmacologist perspective
- Role of artificial intelligence in diagnosing Barrett’s esophagus-related neoplasia
